HTG Molecular Diagnostics Probability of Future Stock Price Finishing Over 0.57

HTGMDelisted Stock  USD 0.57  0.20  54.05%   
HTG Molecular's future price is the expected price of HTG Molecular instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of HTG Molecular Diagnostics performance during a given time horizon utilizing its historical volatility. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
  
Please specify HTG Molecular's target price for which you would like HTG Molecular odds to be computed.

HTG Molecular Target Price Odds to finish over 0.57

The tendency of HTG Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.57 90 days 0.57 
about 81.3
Based on a normal probability distribution, the odds of HTG Molecular to move above the current price in 90 days from now is about 81.3 (This HTG Molecular Diagnostics probability density function shows the probability of HTG Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.75 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, HTG Molecular will likely underperform. Additionally HTG Molecular Diagnostics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   HTG Molecular Price Density   
       Price  

Predictive Modules for HTG Molecular

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as HTG Molecular Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.570.570.57
Details
Intrinsic
Valuation
LowRealHigh
0.540.540.63
Details
Naive
Forecast
LowNextHigh
0.130.130.13
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.140.571.28
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as HTG Molecular. Your research has to be compared to or analyzed against HTG Molecular's peers to derive any actionable benefits. When done correctly, HTG Molecular's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in HTG Molecular Diagnostics.

HTG Molecular Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. HTG Molecular is not an exception. The market had few large corrections towards the HTG Molecular's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold HTG Molecular Diagnostics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of HTG Molecular within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-2.09
β
Beta against Dow Jones3.75
σ
Overall volatility
1.08
Ir
Information ratio -0.13

HTG Molecular Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of HTG Molecular for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for HTG Molecular Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
HTG Molecular is not yet fully synchronised with the market data
HTG Molecular has some characteristics of a very speculative penny stock
HTG Molecular has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 6.37 M. Net Loss for the year was (21.59 M) with loss before overhead, payroll, taxes, and interest of (2.01 M).
HTG Molecular Diagnostics currently holds about 14.1 M in cash with (18.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

HTG Molecular Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of HTG Stock often depends not only on the future outlook of the current and potential HTG Molecular's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. HTG Molecular's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding889.3 K
Cash And Short Term Investments12.2 M

HTG Molecular Technical Analysis

HTG Molecular's future price can be derived by breaking down and analyzing its technical indicators over time. HTG Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of HTG Molecular Diagnostics. In general, you should focus on analyzing HTG Stock price patterns and their correlations with different microeconomic environments and drivers.

HTG Molecular Predictive Forecast Models

HTG Molecular's time-series forecasting models is one of many HTG Molecular's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary HTG Molecular's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about HTG Molecular Diagnostics

Checking the ongoing alerts about HTG Molecular for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for HTG Molecular Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
HTG Molecular is not yet fully synchronised with the market data
HTG Molecular has some characteristics of a very speculative penny stock
HTG Molecular has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 6.37 M. Net Loss for the year was (21.59 M) with loss before overhead, payroll, taxes, and interest of (2.01 M).
HTG Molecular Diagnostics currently holds about 14.1 M in cash with (18.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Consideration for investing in HTG Stock

If you are still planning to invest in HTG Molecular Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the HTG Molecular's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets